Deanna Kepka
Overview
Explore the profile of Deanna Kepka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
1183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nava M, Christini K, Kepka D, Kent-Marvick J, Digre K, Stark L, et al.
Utah Womens Health Rev
. 2025 Feb;
9.
PMID: 39916978
Objectives: Women play an important role in promoting healthy eating and physical activity within their households, influencing the current and life-long health behaviors of children. The purpose of this study...
2.
Garcia K, Alvarez G, Iacob E, Kepka D
Health Promot Pract
. 2025 Jan;
15248399241309897.
PMID: 39846135
Cervical cancer is the leading cause of cancer-related death among Latin American women, including Guatemalans. This is troubling, given we have a vaccine, screening tool, and treatment for this preventable...
3.
Greteman B, Cole A, Charlton M, Shannon J, Kepka D, Paskett E, et al.
BMC Cancer
. 2025 Jan;
25(1):50.
PMID: 39789488
Background: The COVID-19 pandemic involved business closures (e.g., gyms), social distancing policies, and prolonged stressful situations that may have impacted engagement in health behaviors. Our study assessed changes in cancer-related...
4.
Saxena K, Patterson-Lomba O, Gomez-Lievano A, Zion A, Cunningham-Erves J, Kepka D
Front Pediatr
. 2024 Jul;
12:1393897.
PMID: 38993325
Introduction: Routine human papillomavirus (HPV) vaccination in the US is recommended at ages 11 or 12 years and can be given at age 9. Vaccination completion rates among adolescents 13-15...
5.
Buller D, Sussman A, Thomson C, Kepka D, Taren D, Henry K, et al.
JMIR Res Protoc
. 2024 Feb;
13:e50392.
PMID: 38386396
Background: Many emerging adults (EAs) are prone to making unhealthy choices, which increase their risk of premature cancer morbidity and mortality. In the era of social media, rigorous research on...
6.
Garcia K, Iacob E, Dean-Smith M, Royce E, Alvarez G, Kepka D
J Cancer Educ
. 2024 Feb;
39(3):264-270.
PMID: 38376746
Low and middle-income countries, such as Guatemala, shoulder a disproportionate share of cervical cancer, a preventable disease in high income countries. Tangible obstacles, such as lack of access to health...
7.
van Thiel Berghuijs K, Kaddas H, Warner E, Fair D, Fluchel M, Knackstedt E, et al.
BMC Health Serv Res
. 2023 Nov;
23(1):1215.
PMID: 37932718
Background: Vaccinations are a vital part of routine childhood and adolescent preventive care. We sought to identify current oncology provider practices, barriers, and attitudes towards vaccinating childhood and adolescent cancer...
8.
Waters A, Weir C, Kramer H, van Thiel Berghuijs K, Wu Y, Kepka D, et al.
J Cancer Surviv
. 2023 May;
18(5):1481-1491.
PMID: 37147553
Background: Survivors of childhood and adolescent cancer experience low human papillomavirus (HPV) vaccination rates-a crucial form of cancer prevention. Oncology provider recommendations may increase young survivors HPV vaccine intent, but...
9.
Ou J, Bennion N, Parker K, Fair D, Hanson H, Kepka D, et al.
Cancer Epidemiol Biomarkers Prev
. 2023 Apr;
32(5):625-633.
PMID: 37071501
Background: Subsequent malignant neoplasms (SMN; new cancers that arise after an original diagnosis) contribute to premature mortality among adolescent and young adult (AYA) cancer survivors. Because of the high population...
10.
Brandt H, Footman A, Adsul P, Ramanadhan S, Kepka D
Hum Vaccin Immunother
. 2023 Feb;
19(1):2180250.
PMID: 36803261
Human papillomavirus (HPV) vaccination is routinely recommended for adolescents aged 11 or 12 years but can begin at age 9. On-time HPV vaccination by the thirteenth birthday has proven to...